alexa Sclerosing mesenteritis | Canada| PDF | PPT| Case Reports | Symptoms | Treatment

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences
  • International Conference on Clinical Gastroenterology and Hepatology
    August 29-30, 2018 Toronto, Canada
  • 17th International Conference on Gastroenterology and Hepatology
    August 29-30, 2018 Toronto, Canada

Sclerosing Mesenteritis

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
  • Sclerosing mesenteritis

    Sclerosing mesenteritis is an uncommon idiopathic disorder characterised by chronic non-specific inflammation involving the adipose tissue of the bowel mesentery.

    Symptoms:

    Sclerosing mesenteritis is a rare benign condition that is found most often in elderly patients. Various terms are used throughout the literature to describe this condition, which may lead to confusion, especially since there is a paucity of data regarding this rare disease. sclerosing mesenteritis is asymptomatic, gastrointestinal symptoms such as abdominal pain, nausea/vomiting, bloating, loss of appetite, weight loss and diarrhea or constipation, Occasionally, intermittent partial bowel obstruction is encountered. Non-gastrointestinal symptoms include fatigue, weight loss, night sweats and fever.

  • Sclerosing mesenteritis

    Diagnosis:

    Sclerosing mesenteritis is chronic inflammation and fibrosis of the mesentery of unknown etiology. Tests and procedures used to diagnose sclerosing mesenteritis include. 1. Physical exam: sclerosing mesenteritis often forms a mass in upper abdomen that can be felt during a physical exam. 2. Imaging tests: Imaging tests of your abdomen may reveal sclerosing mesenteritis. Imaging tests may include computerized tomography or magnetic resonance imaging. 3. Biopsy: Removing a sample of tissue for testing.

  • Sclerosing mesenteritis

    Statistical analysis:

    Sclerosing mesenteritis is itself non-neoplastic, but it is often associated with an underlying malignancy. The disease usually progresses slowly and may subside spontaneously, around 30%-50% of patients are asymptomatic. However, 20% of patients will have more symptomatic debilitating disease. The most common symptom is chronic abdominal pain, some patients may present with acute abdomen.

 

High Impact List of Articles

Conference Proceedings